title: Outcome for secondary preventive trials (in Mild Cognitive Impairment).
abstract: Preventive trials should first target specific patients' groups, and growing information concerning evolution of patients with mild cognitive impairments should be used for a proper selection. Studies on clinical evolution may also help to select appropriate neuropsychological tests, and prevention can be defined as maintained performance on a battery of tests. Disturbance of daily living activities should be considered since it defines occurrence of dementia. Complementary information can be obtained from behavioural evaluation.
authors.affiliation: E. Salmon, Memory Centre, University Hospital of Liege, Belgium.
authors.forename: E
authors.initials: E
authors.lastname: Salmon
mesh_terms: D000203:Activities of Daily Living; D000368:Aged; D000375:Aging; D015415:Biomarkers; D001921:Brain / Q000473:pathology*; D003072:Cognition Disorders / Q000145:classification / Q000473:pathology / Q000517:prevention & control*; D006801:Humans; D008279:Magnetic Resonance Imaging; D009483:Neuropsychological Tests / Q000592:standards*; D017063:Outcome Assessment, Health Care; D011795:Surveys and Questionnaires
chemical_list: D015415:Biomarkers